Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled Clinical Trial [Phase 1]

View source ↗

Summary

A multicenter Phase 1 randomized, double-blind, double-dummy, placebo-controlled trial evaluating the safety, tolerability, and preliminary efficacy of HRS-7450…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• HRS-7450 injection

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Acute Ischemic Stroke | Phase 1 | Status: COMPLETED